Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor
Author:
Funder
University Grants Commission of Bangladesh
Publisher
Elsevier BV
Subject
Biochemistry,Biophysics
Reference64 articles.
1. Severe COVID-19: a review of recent progress with a look toward the future;Xie;Front Public Health,2020
2. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update;Pal;Cureus,2020
3. Coronavirus disease 2019 (COVID-19): a literature review;Harapan;J Infect Public Health,2020
4. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples;Wu;Lancet Gastroenterol Hepatol,2020
5. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation;Wrapp;Science,2020
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Structure-Based Screening of Potential Drugs against SARS-CoV-2 Variants;The 4th International Electronic Conference on Applied Sciences;2023-10-31
2. Interaction sites in the receptor-binding domain (RBD) of the spike wild-type SARS-CoV-2 protein of the posaconazole (POS) drug and its quantum–mechanical characterization;MRS Advances;2023-10-19
3. Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses;Biomolecules;2023-09-26
4. Reviving the interest in the versatile drug nystatin: A multitude of strategies to increase its potential as an effective and safe antifungal agent;Advanced Drug Delivery Reviews;2023-08
5. Potential of 24-Propylcholestrol as Immunity Inducer against Infection of COVID-19 Virus: In Silico Study Immunomodulatory Drugs;Combinatorial Chemistry & High Throughput Screening;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3